NCT00486291View on ClinicalTrials.gov

Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics

PHASE2CompletedINTERVENTIONAL
Enrollment

210

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

VI-0521

phentermine 15mg/topiramate 100mg

DRUG

Placebo

matched placebo

Trial Locations (9)

Unknown

Research Site, Birmingham

Research Site, Los Angeles

Research Site, San Francisco

Research Site, Spring Valley

Research Site, Walnut Creek

Research Site, Bethesda

Research Site, Austin

Research Site, San Antonio

Research Site, Richmond

All Listed Sponsors
collaborator

Synteract, Inc.

INDUSTRY

lead

VIVUS LLC

INDUSTRY

NCT00486291 - Study of VI-0521 Compared to Placebo in the Glycemic Management of Obese Diabetics | Biotech Hunter | Biotech Hunter